Original Research
Published on 20 Jul 2018
CD38 as Immunotherapeutic Target in Light Chain Amyloidosis and Multiple Myeloma—Association With Molecular Entities, Risk, Survival, and Mechanisms of Upfront Resistance
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2018.01676
- 11,931 views
- 40 citations
